31 assets in Osteoarthritis, Knee

Therapeutic assets addressing Osteoarthritis, Knee, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Dexasone Osteoarthritis, Knee	Poznan University of Medical Sciences	P4	BB (69)
Dexmedetomidine Osteoarthritis, Knee	Poznan University of Medical Sciences	P4	BB (69)
Dextrose Solution Osteoarthritis, Knee	Kastamonu University	P4	BB (69)
Kenacort Osteoarthritis, Knee	Mayo Clinic	P4	BB (69)
Remimazolam Osteoarthritis, Knee	Seoul National University Hospital	P4	BB (69)
Triamcinolone Hexacetonide Osteoarthritis, Knee	Kastamonu University	P4	BB (69)
Liraglutide Osteoarthritis, Knee	Boston Medical Center	P4	BB (68)
Ibuprofen Osteoarthritis, Knee	QC Kinetix LLC	P3	BB (66)
Resiniferatoxin Osteoarthritis, Knee	Sorrento Therapeutics, Inc.	P3	BB (66)
Acetylcysteine Osteoarthritis, Knee	Vanderbilt University Medical Center	P4	BB (65)
Phenol Osteoarthritis, Knee	University of Manitoba	P4	BB (65)
Ropivacaine Osteoarthritis, Knee	Poznan University of Medical Sciences	P4	BB (65)
Tirzepatide Osteoarthritis, Knee	JULIO GRANADOS MONTIEL	P4	BB (65)
Tranexamic Acid Osteoarthritis, Knee	Konkuk University Medical Center	P4	BB (65)
Physiologic Sodium Chloride Solution Osteoarthritis, Knee	Poznan University of Medical Sciences	P4	BB (64)
Retatrutide Osteoarthritis, Knee	Eli Lilly and Company	P3	B (62)
Prothrombin Complex Concentrate Osteoarthritis, Knee	Konkuk University Medical Center	P4	B (61)
Autologous Conditioned Plasma Osteoarthritis, Knee	QC Kinetix LLC	P2	B (60)
Fresh Frozen Plasma Osteoarthritis, Knee	Konkuk University Medical Center	P4	B (59)
Fepixnebart Osteoarthritis, Knee	Eli Lilly and Company	P2	CCC (53)
ly3556050 Osteoarthritis, Knee	Eli Lilly and Company	P2	CCC (53)
ly3857210 Osteoarthritis, Knee	Eli Lilly and Company	P2	CCC (53)
ly4065967 Osteoarthritis, Knee	Eli Lilly and Company	P2	CCC (53)
Oxytocin Osteoarthritis, Knee	Wake Forest University Health Sciences	P2	CCC (53)
(S)-2-(3-Methyl-1-((3-Methyl-1,2,4-Oxadiazol-5-Yl)Methyl)-2,6-Dioxo-1,2,3,6-Tetrahydro-7H-Purin-7-Yl)-N-(6-(2-(Trifluoromethyl)Pyrimidin-5-Yl)Pyridin-2-Yl)Propanamide Osteoarthritis, Knee	Eli Lilly and Company	P2	CCC (53)
Mesocella-Ortho Administration Osteoarthritis, Knee	Jagiellonian University	P1/2	CCC (52)
Metformin Osteoarthritis, Knee	The University of Hong Kong	Early P1	C (39)
Ethylicum Osteoarthritis, Knee	Federal University of São Paulo	N/A	D (30)
Triamcinolone Acetonide 21-Acetate Osteoarthritis, Knee	Brixton Biosciences, Inc.	N/A	D (30)
Kbp-336 Osteoarthritis, Knee	KeyBioscience AG	P2	NR ()
nnc0487-0111 Osteoarthritis, Knee	Novo Nordisk A/S	P3	NR ()